Surprisingly, in contrast to most tumor suppressors generally down-regulated in cancer tissues, we have observed a significant portion of high expression of Sesn2 (20 out of 77) in the examined lung cancer patients, their Sesn2 levels even are much higher than their adjacent normal lung tissues. Here, SESN2 is linked to lung cancer.